Health Service Executive. (2019) HSE performance profile- January - March 2019. Dublin: Health Service Executive.
Preview | Title | Contact |
---|---|---|
|
PDF (HSE performance profile- January - March 2019)
- Published Version
2MB | |
|
PDF (HSE management report - January)
- Supplemental Material
3MB | |
|
PDF (HSE management report - February)
- Supplemental Material
3MB | |
|
PDF (HSE management report - March)
- Supplemental Material
4MB |
Social inclusion figures from the HSE from management data report March 2019
P.101. Substance misuse
- No. of substance misusers (over 18) for whom treatment has commenced within one calendar month following assessment
- % of substance misusers (over 18 years) for whom treatment has commenced within one calendar month following assessment
- No. of substance misusers (under 18 years) for whom treatment has commenced within one week following assessment
- % of substance misusers (under 18 years) for whom treatment has commenced within one week following assessment
P.102. Opioid treatment
- Total no. of clients in receipt of opioid substitution treatment (outside prisons)
- Average waiting time (days) from referral to assessment for opioid substitution treatment
- Average waiting time (days) from opioid substitution assessment to exit from waiting list or treatment commenced
P.103. Needle Exchange
- No of unique individuals attending pharmacy needle exchange
P.144. Methadone Treatment
- Year to date (YTD) actual spend vrs YTD budget
P.87 Tobacco
- No. of smokers who received intensive cessation support from a cessation counsellor
- % of Smokers on cessation programmes who were quit at one month
P.123
- No. of initial tobacco sales to minors test purchase inspections carried out
- No. of inspections of E-Cigarette and Refill Container manufacturers, importers, distributors and retailers under the E.U. (Manufacture, Presentation and Sale of Tobacco and Related Products) Regulations 2016
Item Type
Report
Publication Type
Irish-related, Report
Drug Type
Substances (not alcohol/tobacco), Opioid, Tobacco / Nicotine
Intervention Type
Drug therapy, Treatment method, Screening / Assessment
Date
July 2019
Publisher
Health Service Executive
Corporate Creators
Health Service Executive
Place of Publication
Dublin
EndNote
Accession Number
HRB (Electronic Only)
Subjects
B Substances > Tobacco (cigarette smoking)
HJ Treatment or recovery method > Substance disorder treatment method > Substance replacement method (substitution)
HJ Treatment or recovery method > Substance disorder treatment method > Substance replacement method (substitution) > Opioid agonist treatment (methadone maintenance / buprenorphine)
J Health care, prevention, harm reduction and treatment > Health related issues > Health information and education > Communicable / infectious disease control > Needle syringe distribution and exchange
J Health care, prevention, harm reduction and treatment > Health care delivery
J Health care, prevention, harm reduction and treatment > Health care economics
L Social psychology and related concepts > Waiting for a product or service
VA Geographic area > Europe > Ireland
HJ Treatment or recovery method > Substance disorder treatment method > Substance replacement method (substitution)
HJ Treatment or recovery method > Substance disorder treatment method > Substance replacement method (substitution) > Opioid agonist treatment (methadone maintenance / buprenorphine)
J Health care, prevention, harm reduction and treatment > Health related issues > Health information and education > Communicable / infectious disease control > Needle syringe distribution and exchange
J Health care, prevention, harm reduction and treatment > Health care delivery
J Health care, prevention, harm reduction and treatment > Health care economics
L Social psychology and related concepts > Waiting for a product or service
VA Geographic area > Europe > Ireland
Repository Staff Only: item control page